Figure 2.
Effect of allocation to simvastatin plus ezetimibe treatment on costs of vascular hospital episodes in SHARP (Study of Heart and Renal Protection). 183% of participants in this category with chronic kidney disease (CKD) stage 3b (estimated glomerular filtration rate of 30-<45 mL/min/1.73 m2). Abbreviations: CI, confidence interval; CVD, cardiovascular disease; LDL-C, low-density lipoprotein cholesterol; SE, standard error.